4-ethylamino-5,6-dihydro-6-methyl-7,7-dioxide-4H-thieno(2,3-b)thiopyran-2-sulfonamide,
5,6-dihydro-4-ethylamino-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide,
dorzolamide,
Dorzolamide Chibret,
dorzolamide hydrochloride,
dorzolamide, (trans)-isomer,
L 671152,
L-671,152,
MK 507,
MK-507,
Trusopt,
DORZOLAMIDE HYDROCHLORIDE,
Dorzolamide HCl,
130693-82-2,
Trusopt,
Dorzolomide hydrochloride,
Cosopt,
Dorzolamide (hydrochloride),
UNII-QZO5366EW7,
QZO5366EW7,
MK-507,
Trusopt (TN),
DSSTox_CID_25530,
DSSTox_RID_80933,
DSSTox_GSID_45530,
L 671152,
L-671,152,
C10H16N2O4S3.HCl,
CHEBI:4703,
MK 0507,
MK-0507,
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride,
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride,
Dorzolamide impurity A,
SR-05000001449,
Dorzolamide-HCL,
(4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride,
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride,
Dorzolamide HCl salt,
Dorzolamide hydrochloride [USAN:USP],
L671152 hydrochloride,
NCGC00016977-01,
AC1OCF25,
CAS-130693-82-2,
SCHEMBL41152,
MLS002154162,
CHEMBL1201162,
DTXSID1045530,
CTK8E7974,
HY-B0109A,
KS-00000XJI,
OSRUSFPMRGDLAG-QMGYSKNISA-N,
HMS1571O14,
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, monohydrochloride, (4S-trans)-,
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-4-(ethylamino)-6-methyl-, 7,7-dioxide, monohydrochloride, (4S,6S)-,
Tox21_110720,
ABP001060,
MFCD00884659,
s1375,
AKOS005146235,
AKOS015895951,
Dorzolamide hydrochloride (JP17/USP),
Tox21_110720_1,
AC-5244,
API0007146,
CCG-221116,
CS-1858,
KS-1348,
RTC-070963,
NCGC00179244-03,
BC208520,
CC-27373,
SC-18010,
SMR001233461,
MK-507 (L-671152) HCl,
TC-070963,
D4189,
FT-0082547,
FT-0631133,
D00653,
J10249,
K-4065,
279D961,
I06-1271,
L-671152,
SR-05000001449-3,
Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard,
Dorzolamide hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide 4H-Thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride,
dorzolamide,
Dorzolamide Chibret,
dorzolamide, (trans)-isomer,
C10H16N2O4S3.ClH,
Dorzolamide hydrochloride [USAN],
MK 507,
ACN-031792,
CID6918132,
C10-H16-N2-O4-S3.Cl-H,
A4357,
C062765,
120279-96-1,
4-ethylamino-5,6-dihydro-6-methyl-7,7-dioxide-4H-thieno(2,3-b)thiopyran-2-sulfonamide,
5,6-dihydro-4-ethylamino-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide,